Skip to main content

Wright Richard M.'s Form 4 filing

Celldex Therapeutics, Inc. (CLDX) · filed Nov 17, 2025

Accession no.
0001646423-25-000007
Filed
Nov 17, 2025
Trade date
Nov 13, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.18M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wright Richard M.CIK 0001646423Other: Former Officer

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 13, 2025Common StockMOption exerciseAcquired+6,876$9.02+$62,021.5227,709Direct
Nov 13, 2025Common StockMOption exerciseAcquired+26,672$10.38+$276,855.3654,381Direct
Nov 13, 2025Common StockMOption exerciseAcquired+15,750$22.48+$354,06070,131Direct
Nov 13, 2025Common StockSSaleDisposed−49,298$24.00−$1,183,15220,833Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 13, 2025Common StockMOption exerciseDisposed−6,876$0.00$00Direct
Nov 13, 2025Common StockMOption exerciseDisposed−26,672$0.00$00Direct
Nov 13, 2025Common StockMOption exerciseDisposed−15,750$0.00$07,875Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)